Piracetam solution for injection 20% ampoule 5 ml No. 10

Piracetam is a psychostimulant and nootropic agent. Indications for use

Warehouse

Contraindication

Method of application

Treatment of conditions accompanied by memory impairment and cognitive disorders.

The initial daily dose is 4.8 g during the first week of treatment. Usually the dose should be divided into 2-3 administrations. The maintenance dose is 2.4 g per day. Subsequently, a gradual dose reduction of 1.2 g per day is possible.

Treatment of cortical myoclonus.

The initial daily dose is 24 g for 3 days. If during this time the desired therapeutic effect is not achieved, continue using the drug at the same dosage (24 g/day) for up to 7 days. If the desired therapeutic effect is not achieved on the 7th day of treatment, treatment should be discontinued. If the therapeutic effect has been achieved, then starting from the day when a stable improvement is achieved, start reducing the dose of the drug by 1.2 g of piracetam every 2 days until the manifestations of cortical myoclonus reappear. This will make it possible to establish an average effective dose.

Application features

Effect on platelet aggregation.

Due to the fact that piracetam reduces platelet aggregation, the drug should be prescribed with caution to patients with impaired hemostasis, conditions that may be accompanied by bleeding (gastrointestinal ulcer), during major surgical operations (including dental interventions), patients with symptoms of severe bleeding or patients with a history of hemorrhagic stroke; patients taking anticoagulants, platelet antiaggregants, including low doses of acetylsalicylic acid. The drug is excreted by the kidneys, so special attention should be paid to patients with renal failure.

Elderly patients. During long-term therapy in elderly patients, regular monitoring of renal function is recommended, and if necessary, the dose should be adjusted depending on the results of the creatinine clearance study.

When treating patients with cortical myoclonus, abrupt interruption of treatment should be avoided due to the risk of generalization of myoclonus or the occurrence of seizures.

Penetrates through the filter membranes of hemodialysis machines.

This medicine contains 1 mmol (23 mg) of sodium per 24 g of piracetam. This should be taken into consideration by patients on a controlled sodium diet.

Pregnant women

The drug should not be used during pregnancy or breastfeeding.

Children

Do not use in this category of patients.

Drivers

Caution should be exercised when driving or operating other machinery.

Overdose

Symptoms of overdose were observed with oral administration of the drug at a dose of 75 g.

Treatment is symptomatic. There is no specific antidote, hemodialysis can be used (removal of 50-60% of piracetam).

Side effects

Blood and lymphatic system disorders: hemorrhagic disorders.

Immune system disorders: hypersensitivity, anaphylactoid reactions.

Mental disorders: nervousness, depression, increased excitability, anxiety, confusion, hallucinations.

From the nervous system: hyperkinesia, drowsiness, ataxia, balance disorders, increased frequency of epileptic seizures, headache, insomnia, tremor.

On the part of the organs of hearing and balance, dizziness.

Storage conditions

Store in original packaging at a temperature not exceeding 25 ° C. Keep out of the reach of children.